Umeå University's logo

umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Combination of gallium citrate and levofloxacin induces a distinct metabolome profile and enhances growth inhibition of multidrug-resistant Mycobacterium tuberculosis compared to linezolid
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk mikrobiologi. Department of Microbiology, Virology and Biotechnology, Faculty of Biology, Odesa I.I. Mechnikov National University, Odesa, Ukraine.
Odesa Center for Socially Significant Diseases of Odesa Regional Council, Odesa, Ukraine.
Department of Microbiology, Virology and Biotechnology, Faculty of Biology, Odesa I.I. Mechnikov National University, Odesa, Ukraine.
Department of Microbiology, Virology and Biotechnology, Faculty of Biology, Odesa I.I. Mechnikov National University, Odesa, Ukraine.
Vise andre og tillknytning
2024 (engelsk)Inngår i: Frontiers in Microbiology, E-ISSN 1664-302X, Vol. 15, artikkel-id 1474071Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Introduction: Tuberculosis (TB) treatment typically involves a tailored combination of four antibiotics based on the drug resistance profile of the infecting strain. The increasing drug resistance of Mycobacterium tuberculosis (Mtb) requires the development of novel antibiotics to ensure effective treatment regimens. Gallium (Ga) is being explored as a repurposed drug against TB due to its ability to inhibit Mtb growth and disrupt iron metabolism. Given the potential interactions between Ga and established antibiotics, we investigated how a combination of Ga with levofloxacin (Lfx) or linezolid (Lzd) affects the growth and metabolome of a multidrug-resistant (MDR) Mtb clinical strain.

Methods: Mtb was cultured using a BACTEC 960 system with concentrations of Ga ranging from 125 to 1,000 μM and with 250 to 500 μM of Ga combined with 0.125 mg/L of Lfx or Lzd. For metabolome analysis, the antibacterials were used at concentrations that inhibited the growth of bacteria without causing cell death. Metabolites were extracted from Mtb cells and analyzed using chromatography-mass spectrometry.

Results: The MDR Mtb strain exhibited a dose-dependent response to Ga. Notably, the enhancement in growth inhibition was statistically significant for the Ga/Lfx combination compared to Ga alone, while no such significance was observed for Ga/Lzd. Moreover, exposure to Ga/Lfx or Ga/Lzd resulted in distinct metabolite profiles. Ga treatment increased the level of aconitate, fumarate, and glucose in the cells, suggesting the inhibition of iron-dependent aconitase and fumarate hydratase, as well as disruption of the pentose phosphate pathway. The levels of glucose, succinic acid, citric acid, and hexadecanoic acid followed a similar pattern in cells exposed to Ga and Ga/Lfx at 500 μM Ga but exhibited different trends at 250 μM Ga.

Discussion: In the presence of Lfx, the Mtb metabolome changes induced by Ga are more pronounced compared to those observed with Lzd. Lfx affects nucleic acids and transcription, which may enhance Ga-dependent growth inhibition by preventing the metabolic redirection that bacteria typically use to bypass iron-dependent enzymes.

sted, utgiver, år, opplag, sider
Frontiers Media S.A., 2024. Vol. 15, artikkel-id 1474071
Emneord [en]
levofloxacin, metabolome, drug resistance, central metabolism, Mycobacterium tuberculosis, gallium, linezolid, drug–drug interaction
HSV kategori
Identifikatorer
URN: urn:nbn:se:umu:diva-232554DOI: 10.3389/fmicb.2024.1474071ISI: 001379467900001PubMedID: 39697659Scopus ID: 2-s2.0-85212408140OAI: oai:DiVA.org:umu-232554DiVA, id: diva2:1917701
Forskningsfinansiär
EU, European Research CouncilThe Kempe FoundationsScience for Life Laboratory, SciLifeLabTilgjengelig fra: 2024-12-03 Laget: 2024-12-03 Sist oppdatert: 2025-01-08bibliografisk kontrollert

Open Access i DiVA

fulltext(1988 kB)78 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 1988 kBChecksum SHA-512
9757492a782c49dac8f4a9e8a0eea0c8fed715c362f7e17a4b68ae37390a83a8919d3ed3c0ad8213e4e724c5c1fdbb9820f9808618d7d0c18d2e42b1430e048e
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Ilchenko, OleksandrRamstedt, MadeleineRzhepishevska, Olena

Søk i DiVA

Av forfatter/redaktør
Ilchenko, OleksandrRamstedt, MadeleineRzhepishevska, Olena
Av organisasjonen
I samme tidsskrift
Frontiers in Microbiology

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 78 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 259 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf